Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KdPT in mild to moderate ulcerative colitis
2011-002462-20Phase 2Completed
- Sponsor
- Dr. August Wolff
- Start
- Sep 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of KdPT in autoimmune colitis (4 arms), sponsored by Dr. August Wolff. Primary endpoint: Time to sustained response to study medication. Started Sep 2011; status: completed.
02
Drugs
KdPT
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2011-002462-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002462-20.